Skip to main content

Table 1 Baseline characteristics of all randomized patients from Asia, Central Europe, and Latin America (n = 171a)

From: Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial

Characteristic

QW/QW (n = 86)

BIW/QW (n = 85)

p value

Age, years

45.8 (13.0)

44.8 (12.0)

0.581

Male gender, n ( %)

64 (74.4)

63 (74.1)

1.000

Race, n (%)

  

0.898

 White

44 (51.2)

46 (54.1)

 

 Asian

25 (29.1)

22 (25.9)

 

 Other

17 (19.8)

17 (20.0)

 

Body weight, kg

87.3 (19.3)

84.5 (17.1)

0.311

Body mass index, kg/m2

   

 Male

28.9 (5.1)

28.2 (4.4)

0.438

 Female

32.8 (8.4)

30.4 (6.7)

0.295

Waist to hip ratio

   

 Male

1.0 (0.1)

1.0 (0.1)

0.289

 Female

0.9 (0.1)

0.9 (0.1)

0.501

Current smokers, n (%)

29 (33.7)

25 (29.4)

0.622

Psoriasis disease duration, years

17.0 (10.8)

15.8 (7.8)

0.440

PASI total score

22.2 (9.7)

22.4 (9.4)

0.905

PGA score

3.4 (0.8)

3.4 (0.7)

0.955

Affected body surface area, %

38.0 (22.6)

36.9 (19.6)

0.743

History of psoriatic arthritis, n (%)

32 (37.2)

32 (37.7)

1.000

Duration of psoriatic arthritis, years

7.5 (7.1)

7.7 (5.6)

0.903

Secondary diagnosis of diabetes, n (%)

9 (10.5)

12 (14.1)

0.494

Secondary diagnosis of hypertension, n (%)

37 (43.0)

37 (43.5)

1.000

DLQI score

14.8 (8.4)

14.8 (7.2)

0.967

EQ-5D score

0.6 (0.3)

0.6 (0.3)

0.856

WPAI: % activity impairment due to problem

39.3 (31.2)

42.6 (30.5)

0.487

WPAI: % impairment while working due to problem

23.2 (25.0)

25.8 (24.8)

0.603

WPAI: % overall work impairment due to problem

27.1 (26.0)

27.1 (24.8)

0.999

WPAI: % work time missed due to problem

8.3 (20.7)

4.8 (19.5)

0.378

FACIT score

35.9 (11.4)

37.3 (9.4)

0.368

  1. aData are given as mean (SD) unless otherwise specified
  2. BIW twice weekly, DLQI Dermatology Life Quality Index, EQ-5D EuroQOL 5 Dimension, FACIT Functional Activity in Chronic Therapy, PASI Psoriasis Area and Severity Index, PGA Physician Global Assessment of psoriasis, QW once weekly, WPAI Work Productivity and Activity Impairment scale